Non-interventional, retrospective/prospective, multicenter registry to document the treatment practice of patients with STIC (serous tubal intraepithelial carcinoma) or STIL (serous tubal intraepithelial lesion) in clinical routine

Non-interventional, retrospective/prospective, multicenter registry to document the treatment practice of patients with STIC (serous tubal intraepithelial carcinoma) or STIL (serous tubal intraepithelial lesion) in clinical routine - STIC-registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035307

Enrollment

250

Registered

2024-10-21

Start date

2025-02-19

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D07.3

Interventions

Group 1: Patients with STIC (serous tubal intraepithelial carcinoma)/ STIL (serous tubal intraepithelial lesion) The following data categories are recorded in the eCRF: - Reporter data (structure of

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Confirmed diagnosis of STIC/STIL regardless of stage, treatment form, and line of therapy.

Exclusion criteria

Exclusion criteria: - Missing histological confirmation - Missing informed consent (prospectively enrolled patients)

Design outcomes

Primary

Measure	Time frame
Establishment of a STIC (STIL) registry	—

Secondary

Measure	Time frame
- Stage and extent of extra-tubal STIC lesions - Incidence of pelvic high-grade serous carcinomas after isolated STIC (STIL) diagnosis - Assessment of anamnestic risk factors and genetic risk factors of the patients - Assessment of histopathological diagnostics in daily routine - Assessment of clinical-radiological diagnostics and their significance - Documentation of performed therapies - Documentation of follow-up care - Progression-free survival, disease-specific survival, and overall survival of the patients	—

Measure

Time frame

- Stage and extent of extra-tubal STIC lesions - Incidence of pelvic high-grade serous carcinomas after isolated STIC (STIL) diagnosis - Assessment of anamnestic risk factors and genetic risk factors of the patients - Assessment of histopathological diagnostics in daily routine - Assessment of clinical-radiological diagnostics and their significance - Documentation of performed therapies - Documentation of follow-up care - Progression-free survival, disease-specific survival, and overall survival of the patients

—

Countries

Germany

Contacts

Public ContactValerie ; Linz;

Universitätsmedizin Mainz;IDG Institut für digitale Gesundheitsdaten RLP gGmbH

valerie.linz@unimedizin-mainz.de;support@idg-rlp.de+49 6131 17 7311;

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026